Intratracheal Suctioning and Oxygenation at Extubation
INNOVATE
1 other identifier
observational
250
1 country
1
Brief Summary
Data analysis of routinely applied extubation procedures on the ICU: i.e. extubation with 100% O2 vs. 35% O2 with/without suctioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2018
CompletedFirst Posted
Study publicly available on registry
March 16, 2018
CompletedStudy Start
First participant enrolled
October 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedJanuary 26, 2023
January 1, 2023
3.2 years
March 9, 2018
January 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in proportion of patients with need for ongoing ventilatory support
30 days max follow-up
Study Arms (2)
Extubation with 100% O2
for further information please refer to study protocol
Extubation with 35% O2
for further information please refer to study protocol
Interventions
Eligibility Criteria
ICU patients that undergo routine extubation
You may qualify if:
- All adult (≥18 years) ICU patients with routine extubation on the ICU during the 2-month observational interval.
You may not qualify if:
- Age \< 18 years
- Patients on comfort therapy and/ or terminal extubation or accidental extubationtracheostomized patients
- Patients with refusal to general consent or withdrawal of general consent (DLF and/or internal database)
- Patients dying without next-of-kin available
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jörg Schefoldlead
Study Sites (1)
Dept. of Intensive Care Medicine, University of Bern,
Bern, 3010, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joerg C Schefold, MD
Inselspital, University of Bern
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Sponsor-investigator
Study Record Dates
First Submitted
March 9, 2018
First Posted
March 16, 2018
Study Start
October 7, 2019
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
January 26, 2023
Record last verified: 2023-01